Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protocol for MR1-ligand cross-linking to discover metabolite antigens by proteomics. | STAR Protoc | 2026 | 41779616 | PubTator, text mining | PubMed |
| Unified protein-small molecule graph neural networks for binding site prediction. | Proc Natl Acad Sci U S A | 2026 | 41774792 | PubTator, text mining | PubMed |
| An integrated framework for proactive deepfake mitigation via attention-driven watermarking and blockchain-based authenticity verification. | Sci Rep | 2026 | 41771969 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in colorectal cancer: advances in targeted delivery and personalized oncology. | Front Bioeng Biotechnol | 2026 | 41768137 | PubTator, text mining | PubMed |
| Evaluating the Applicability of Advanced Large Language Models in Laboratory Medicine Test Questions: A Comparative Performance Study. | Adv Med Educ Pract | 2026 | 41766931 | PubTator, text mining | PubMed |
| Platelet transcriptomics sense disease states. | EBioMedicine | 2026 | 41763180 | PubTator, text mining | PubMed |
| Precision fragment addition: domain-specific DeepFrag2 models for smarter lead optimization. | Digit Discov | 2026 | 41756346 | PubTator, text mining | PubMed |
| m5C: Novel Diagnostic and Drug Repurposing Targets for Nonalcoholic Steatohepatitis. | Int J Genomics | 2026 | 41755884 | PubTator, text mining | PubMed |
| Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy. | Pharmaceuticals (Basel) | 2026 | 41754865 | PubTator, text mining | PubMed |
| An Integrated Network Biology and Molecular Dynamics Approach Identifies CD44 as a Promising Therapeutic Target in Multiple Sclerosis. | Pharmaceuticals (Basel) | 2026 | 41754795 | PubTator, text mining | PubMed |
| Bone-CNN: A Lightweight Deep Learning Architecture for Multi-Class Classification of Primary Bone Tumours in Radiographs. | Biomedicines | 2026 | 41751198 | PubTator, text mining | PubMed |
| Progress of Research on the Metabolic Regulation of Lactylation in Muscle Tissues and Its Disease Associations. | Biomolecules | 2026 | 41750282 | PubTator, text mining | PubMed |
| Emerging Protein Targets in Triple-Negative Breast Cancer: Beyond Conventional Therapy. | Cancers (Basel) | 2026 | 41749871 | PubTator, text mining | PubMed |
| Trop2-Based Antibody-Drug Conjugates: Emerging Strategy and Progress in Triple-Negative Breast Cancer Therapy. | Curr Oncol | 2026 | 41744856 | PubTator, text mining | PubMed |
| Cellular strategies for repairing trapped protein-DNA complexes. | Front Pharmacol | 2026 | 41743125 | PubTator, text mining | PubMed |
| Exploring immune-inflammatory cross-talk in atherosclerosis using AI-enhanced multi-omics approaches. | Clin Exp Med | 2026 | 41739231 | PubTator, text mining | PubMed |
| DNA topological regulation in RNA polymerase II transcription. | Cell Mol Biol Lett | 2026 | 41735852 | PubTator, text mining | PubMed |
| Conserving threatened plant species with widespread distribution: A case study of lethal utilization of anticancer Nothapodytes trees in Asia. | Plant Divers | 2026 | 41726810 | PubTator, text mining | PubMed |
| Platelets as immune sensors: monitoring immune dynamics and diagnosing disease states across multiple disorders. | EBioMedicine | 2026 | 41719795 | PubTator, text mining | PubMed |
| Proteome-Wide Analysis of Functional Phosphosites in the FGFR Family of Proteins: Insights from Large-Scale Phosphoproteomic Analysis. | Proteomes | 2026 | 41718090 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=5